Press release
Global High Throughput Screening Market Poised for Growth Amid Advancements in Automation and Personalized Medicine
High Throughput Screening Market
Click To get SAMPLE PDF (Including Full TOC, Graphs & Charts, Table & Figures)@ https://www.emergenresearch.com/request-sample/2682
Market Drivers: Automation, Robotics, and Personalized Medicine
A key factor contributing to the growth of the HTS market is the adoption of advanced automation and robotics technologies. Automated systems are enhancing the efficiency of drug discovery by streamlining processes such as liquid handling, sample preparation, and data analysis. This technological advancement enables researchers to screen large volumes of compounds with higher accuracy and speed, reducing costs and improving overall productivity.
Additionally, the focus on personalized medicine has surged, with HTS playing a crucial role in identifying compounds that target specific biological pathways. By exploring diverse compound libraries, HTS allows researchers to discover innovative therapeutic solutions tailored to individual patient profiles. This personalized approach is driving demand for HTS technologies in both pharmaceutical and biotechnology sectors.
Challenges: High Capital Investment
Despite the promising growth trajectory, the HTS market faces challenges due to the high initial investment required for acquiring cutting-edge equipment and technologies. The substantial capital expenditure associated with implementing state-of-the-art HTS systems can be a barrier, particularly for smaller companies. Furthermore, ongoing maintenance costs, personnel training, and technology upgrades add to the financial burden. However, as the technology continues to evolve and become more widely adopted, these challenges are expected to be mitigated.
Technology Insights: Cell-Based Assays Lead the Way
In terms of technology, cell-based assays have emerged as the dominant segment in the HTS market. This segment accounted for the largest market share in 2022, driven by the increasing relevance of 3D cell culture and the need for more physiologically accurate environments in drug screening. Cell-based assays provide researchers with a more natural context for studying cellular responses, making them an invaluable tool in the early stages of drug development.
Moreover, advancements in automation and molecular biology techniques have further enhanced the capabilities of cell-based assays, allowing for more efficient screening of large compound libraries. These technological developments have made cell-based assays a preferred choice in drug discovery projects, contributing to their growing adoption across the industry.
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/high-throughput-screening-market
Application Insights: Drug Discovery Programs Hold Largest Market Share
The drug discovery programs segment has maintained its leadership in the HTS market, accounting for the largest share in 2022. The rising demand for new therapeutic solutions, particularly in the areas of precision medicine and targeted therapies, is driving the growth of this segment. HTS plays a critical role in early-stage drug discovery by enabling the rapid identification of lead compounds with potential efficacy.
The expansion of target-based drug discovery and the increasing collaboration between pharmaceutical companies and research institutions are also fueling the demand for HTS technologies in drug discovery programs. By accelerating the identification of viable drug candidates, HTS helps to streamline the drug development process, allowing companies to bring new treatments to market more efficiently.
End-Use Insights: Pharmaceutical and Biotechnology Firms Lead Adoption
Pharmaceutical and biotechnology firms continue to be the largest end-users of HTS technologies, driven by the increasing complexity of drug targets and the need for efficient drug discovery processes. The shift towards personalized medicine, where treatments are tailored to individual patient profiles, has intensified the demand for HTS in these industries.
Additionally, the growing complexity of drug targets, such as proteins involved in disease mechanisms, has led to an increased reliance on HTS to screen compounds against these targets. As a result, HTS has become an essential tool in modern drug discovery, enabling companies to accelerate the development of new therapies.
High Throughput Screening Top Companies and Competitive Landscape
The global high throughput screening market is fairly fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective high throughput screening solutions.
Some major players included in the global high throughput screening market report are:
Agilent Technolgies Inc.
Aurora Biomed Inc.
Danaher Corporation
Bio-Rad Laboratories
Perkin Elmer
Merck KGaA Group
Tecan Group
Luminex Corporation
Axxam S.P.A
Hamilton Company
Make Payment [Buy your Exclusive copy] @ https://www.emergenresearch.com/select-license/2682
High Throughput Screening Latest Industry Updates
On 28 February 2023, Beckman Coulter Life Sciences, which is U.S.-based leading provider of laboratory workflow automation and innovation solutions announced strategic collaboration with life science analytical technologies company Sciex to provide comprehensive workflows for high-throughput screening, and synthetic biology This strategic move is intended to boost operational capabilities by deploying cutting-edge technologies, enhance early stage drug discovery, and eventually boost business revenue.
For the purpose of this report, Emergen Research has segmented global high throughput screening market on the basis of technology, application, end-use, and region:
Technology Outlook (Revenue, USD Billion; 2019-2032)
Cell-based Assays
Ultra High Throughput Screening
Application Outlook (Revenue, USD Billion; 2019-2032)
Drug discovery programs
Biochemical screening
Chemical biology programs
Cell & organ-based screening
End-Use Outlook (Revenue, USD Billion; 2019-2032)
Pharmaceutical and Biotechnology Firms
Academia and Research Institutes
Regional Outlook (Revenue, USD Billion; 2019-2032)
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Benelux
Russia
Rest of Europe
Asia Pacific
China
Japan
South Korea
India
ASEAN Countries
Oceania
Rest of APAC
Latin America
Brazil
Mexico
Rest of LATAM
Middle East & Africa
GCC Countries
Israel
Turkey
South Africa
Rest of MEA
Request For Customization Report@ https://www.emergenresearch.com/request-for-customization/2682
Look Over transcripts provided by Emergen Research
High Throughput Screening Market Size@ https://www.emergenresearch.com/industry-report/high-throughput-screening-market/market-size
High Throughput Screening Market Share@ https://www.emergenresearch.com/industry-report/high-throughput-screening-market/market-share
High Throughput Screening Market Trends@ https://www.emergenresearch.com/industry-report/high-throughput-screening-market/market-trends
High Throughput Screening Regional Market Demand@ https://www.emergenresearch.com/industry-report/high-throughput-screening-market/regional-market-demand
High Throughput Screening Market Analysis@ https://www.emergenresearch.com/industry-report/high-throughput-screening-market/market-analysis
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global High Throughput Screening Market Poised for Growth Amid Advancements in Automation and Personalized Medicine here
News-ID: 3687147 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for HTS
High Throughput Screening (HTS) Market to Reach $47.41 Billion by 2031
Meticulous Research®, a globally recognized leader in market research, has unveiled its latest industry report, "High Throughput Screening Market by Technology (Cell-based Assays [2D, 3D], Label-free, Lab-on-chip), Offering (Reagents, Liquid Handling, Readers, Sample Preparation), Application (Target Identification, Toxicology, Stem Cell), End User - Global Forecast to 2031." The report projects the global High Throughput Screening (HTS) market to achieve an estimated value of $47.41 billion by 2031, growing at a…
High Throughput Screening Market - Advancing Drug Discovery: HTS Propelling Ther …
Newark, New Castle, USA - new report, titled High Throughput Screening Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the High Throughput Screening market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global High Throughput Screening market. The report offers an overview of…
High-Throughput Sequencing (HTS) Market 2022 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the High-Throughput Sequencing (HTS) market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players' performance based on revenue generation and client requirements. Also, the research report reveals…
Global High Throughput Screening (HTS) Market Analysis (2020-2025)
Global Info Research offers a latest published report on High Throughput Screening (HTS) Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global High Throughput Screening (HTS) Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report…
Global High Throughput Screening (HTS) Sales Market Report to 2021
Bigmarketresearch.com include new market research report “Global High Throughput Screening (HTS) Sales Market - Size, Share, Trends, Forecast 2021”
This report studies sales (consumption) of High Throughput Screening (HTS) in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Agilent Technologies, Inc. (U.S.)
PerkinElmer (U.S.)
Get Sample Copy of report…
HTS expands to Dubai
HTS Global Tecnologies Ltd. with headquarters in Zug (Switzerland) establishes yet another international selling agency. The recently opened subsidiary in Dubai employs four employees and coordinates all regional distribution activities and distribution channels with immediate effect.
“The middle eastern markets, especially those of the UAE, are high potential markets for our products”, said Fabian de Soet, CEO of HTS Global Technologies during the opening ceremony in Dubai.
HTS Global…
